MD 0727
Alternative Names: MD-0727Latest Information Update: 28 Apr 2008
At a glance
- Originator Microbia
- Developer Ironwood Pharmaceuticals
- Class
- Mechanism of Action Cholesterol absorption inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercholesterolaemia
Most Recent Events
- 21 Sep 2005 Phase-I clinical trials in Hypercholesterolaemia in USA (PO)